Robert M Wenham

4PUBLICATIONS
35CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 04, 2026
Olaparib plus tremelimumab in women with recurrent ovarian cancer and a germline BRCA1 or BRCA2 mutation: a phase I/II study.

|Sep 07, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).

Janos L Tanyi, Leslie M Randall, Setsuko K Chambers

|May 02, 2022
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors.

Alexandra L Martin, Carmen M Anadon, Subir Biswas

|Apr 19, 2022
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.

Siqing Fu, Bradley R Corr, Kerry Culm-Merdek

Pageof 1

Frequent Collaborators

2 joint publications

Jose R Conejo-Garcia

1 joint publications

Siqing Fu

1 joint publications

R Wendel Naumann

1 joint publications

Rafael D Rosengarten